Sol-Gel Technologies Ltd. operates as a clinical-stage dermatology company, which engages in the identification, development, and commercialization of topical dermatological drug products for the treatment of skin diseases. The firm is focused on identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The Company’s offers a range of products twins, sirs-t, and vered. The firm is designed its proprietary, silica-based microencapsulation technology platform to enhance the tolerability and stability of topical drugs while maintaining their efficacy. Topical drugs often struggle to balance achieving both high efficacy and high tolerability. Its technology platform entraps active ingredients in an inert, inorganic silica shell, which creates an unnoticeable barrier between the active ingredient and the skin.
Quelle est la performance du prix de l'action SLGL ?
Le prix actuel de SLGL est de $81.49, il a augmenté de 1.84% lors de la dernière journée de trading.
Quels sont les thèmes d'affaires principaux ou les industries de Sol Gel Technologies Ltd ?
Sol Gel Technologies Ltd appartient à l'industrie Pharmaceuticals et le secteur est Health Care
Quel est la capitalisation boursière de Sol Gel Technologies Ltd ?
La capitalisation boursière actuelle de Sol Gel Technologies Ltd est de $227.3M
Est-ce que Sol Gel Technologies Ltd est un achat, une vente ou un maintien ?
Selon les analystes de Wall Street, 3 analystes ont établi des notations d'analystes pour Sol Gel Technologies Ltd, y compris 2 achat fort, 4 achat, 1 maintien, 0 vente et 2 vente forte